Rbc Life Sciences logo

Rbc Life Sciences(OTC) RBCL

Market Cap$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-100%
5 Year-99%
1 Year+600%
1 Month-0%
$0.00
+0.00%
+0.00Today
Rbc Life Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-04
Rbc Life Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.14%USD 0.002026-04-09
1 month-0.14%USD 0.002026-04-09
3 month-0.14%USD 0.002026-04-09
Year to date+75%USD 0.002025-12-15
1 year+600%USD 0.002025-07-08
3 year+133.33%USD 0.002023-07-24
5 year-99%USD 0.072021-09-02
Since inception-100%USD 30.631997-04-02

Rbc Life Sciences Financials at a Glance

Market Cap

$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$23.60M

Net Income (TTM)

-$690.29K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-13.11 (Low)

Price

$0.00

Volume

400

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 21, 2024

RBCL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rbc Life Sciences

RBC Life Sciences, Inc. is a manufacturer and distributor of nutritional supplements and personal care products. Headquartered in Irving, Texas, the company focuses on wellness, weight loss, sports, and fitness products.

Products and Services
  • Nutritional supplements for various health needs
  • Personal care products aimed at enhancing wellness
  • Weight loss and fitness solutions for active lifestyles
Growth Outlook
  • Recent quarterly revenue reached $4.9 million, indicating strong market demand
  • Trailing twelve months (TTM) gross profit margin stands at 52.8%, showcasing operational efficiency
  • Current ratio of 2.28 suggests solid liquidity and financial health
Financial Highlights
  • Net income for the latest quarter was -$350,413, reflecting ongoing challenges
  • Cash and cash equivalents totaled $685,431, providing a buffer for operations
  • Inventory turnover ratio of 2.93 indicates effective inventory management
RBC Life Sciences, Inc. operates in the consumer defensive sector, focusing on health and wellness products. The company has shown resilience in its revenue generation, with a recent quarterly revenue of $4.9 million. Despite facing challenges reflected in the net income figures, the gross profit margin of 52.8% indicates a strong ability to manage costs effectively. The current ratio of 2.28 further emphasizes the company's liquidity position, allowing it to meet short-term obligations comfortably. The inventory turnover ratio of 2.93 suggests that RBC Life Sciences is managing its inventory efficiently, which is crucial for maintaining cash flow and reducing holding costs. The cash reserves of $685,431 provide a safety net for operational needs, allowing the company to navigate through periods of financial strain. Overall, RBC Life Sciences, Inc. presents a compelling case for potential investors interested in the health and wellness sector, with a focus on operational efficiency and market demand.
AI Generated • Aug 28, 2026

Industry

Personal Products

Headquarters

Irving, TX 75038, US

RBCL Financials

Key Financial Metrics (TTM)

Gross Margin

52.82%

Operating Margin

-2.59%

Net Income Margin

-2.93%

Return on Equity

-10.08%

Return on Capital

-9.34%

Return on Assets

-6.90%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.21M

Volume

400

Avg. Volume

6.349

Financials (TTM)

Gross Profit

$12.41M

Operating Income

-$789.85K

EBITDA

-$451.87K

Operating Cash Flow

-$349.54K

Capital Expenditure

-$121.84K

Free Cash Flow

-$471.38K

Cash & ST Invst.

$685.43K

Total Debt

$0.00

Rbc Life Sciences Performance Analysis

Rbc Life Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42016-12-31-1.0%
Q12017-03-31-21.4%
Q22017-06-300.6%
Q32017-09-30-14.6%
Rbc Life Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42016-12-31-340.0%
Q12017-03-31116.7%
Q22017-06-30-360.0%
Q32017-09-30-207.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2017YOY CHG

Revenue

$4.90M

-33.1%

Gross Profit

$2.54M

-35.0%

Gross Margin

51.79%

N/A

Market Cap

$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$16.85

N/A

Employees

89

N/A

Net Income

-$350.41K

-428.6%

EBITDA

-$270.00K

-167.8%

Quarterly Fundamentals

Name
Q3 2017YOY CHG

Total Cash

$685.43K

-47.1%

Total Debt

$0.00

N/A

Accounts Receivable

$1.28M

-17.1%

Inventory

$5.78M

+40.8%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-6.90%

N/A

Return on Invested Capital

-8.78%

N/A

Free Cash Flow

-$92.85K

-116.7%

Operating Cash Flow

-$80.99K

-114.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCGRPC Group, Inc.
$0.00+0.00%
TUEMQTuesday Morning Corporation
$0.00+0.00%
ANFIFAmira Nature Foods Ltd.
$0.00+0.00%
PACVPacific Ventures Group, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$51.73+17.20%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$101.13-16.98%
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$18.57-19.51%
NOKNokia
$9.65-13.30%

Questions About RBCL

What is the current price of Rbc Life Sciences?

Rbc Life Sciences is trading at $0.00 per share.

What is the 52-week range for Rbc Life Sciences?

Over the past 52 weeks, Rbc Life Sciences has traded between $0.00 and $0.00.

How much debt does Rbc Life Sciences have?

Rbc Life Sciences total debt is unavailable.

How much cash does Rbc Life Sciences have on hand?

Rbc Life Sciences does not have cash on hand data available.

What is Rbc Life Sciences’s dividend yield?

Rbc Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.